Given the nearly ubiquitous expression of Eph receptors on immune cells, the function that these receptors play in cancer immunology must also be understood in order to rationally design Eph-based anti-cancer therapeutics that incorporate the contributions of Eph receptors to the immune control of cancers. This evidence concerns the gene EPHA1 and cancer.